Skip to main content
Fig. 1 | BMC Public Health

Fig. 1

From: Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis

Fig. 1

Flow diagram detailing selection of cases included in the analyses. TST indicates tuberculin skin test; IGRA indicates interferon gamma release assay; LTBI indicates latent tuberculosis infection; INH indicates Isoniazid. * Others were offered either three months of isoniazid and rifapentine (3HP) or four months of rifampin (4R) ** Includes 28 observations where all demographic and clinical data were the same but treatment outcome differed

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us